Patent Assignment
Reel/Frame 057886/0192
Release of Security Interest
Recorded: 2021-10-21
Pages: 24
Assignor
CORTLAND CAPITAL MARKET SERVICES LLC
Executed: 2016-07-27
Assignee
KADMON CORPORATION, LLC
450 EAST 29TH STREET, NEW YORK, NEW YORK, 10016
Covered Properties
(23)
Farnesyl Derivatives and Pharmaceutical Compositions Containing Them
Patent:
5,705,528 →
Application:
08/338,764 →
Non-Malignant Disease Treatment with Ras Antagonists
Patent:
6,462,086 →
Application:
09/597,332 →
Treatment of Post-Angioplasty Restenosis and Atherosclerosis with Ras Antagonists
Farnesyl Derivatives and Pharmaceutical Compositions Containing Them
Patent:
39,682 →
Application:
11/093,255 →
Inhibitors of Microsomal Triglyceride Transfer Protein and Apo-B Secretion
Antibodies That Bind Mmp-14
Methods and Compositions for Oral Delivery of Fts
Methods of Making Pharmacokinetically Improved Compounds Comprising Functional Residues or Groups and Pharmaceutical Compositions Comprising Said Compounds
Application:
11/884,811 →
Publication:
US 2011/0172422
Pharmacokinetically Improved Compounds
Compositions and Methods for Treating Osteolytic Disorders Comprising Mmp-14 Binding Proteins
Evaluating Mmp Expression in Patient Stratification and Other Therapeutic, Diagnostic and Prognostic Methods for Cancer
Methods and Compositions Comprising Anti-Idiotypic Antibodies to Anti-MMP-14 Antibodies
Application:
12/429,338 →
Publication:
US 2009/0275124
Pharmacokinetically Improved Compounds
Application:
12/438,504 →
Publication:
US 2010/0324037
Treatment of Lung Cancer
Pharmacokinetically Improved Compounds
Application:
12/570,153 →
Publication:
US 2010/0093719
Alkoxyalkyl S-Prenylthiosalicylates for Treatment of Cancer
Metalloproteinase Binding Proteins
Methods of Treating Hepatitis C Virus Infection
Application:
13/078,344 →
Publication:
US 2011/0243894
Combination Treatments Comprising Protease Binding Proteins for Inflammatory Disorders
Application:
13/124,046 →
Publication:
US 2011/0262396
Method for Treating Breast Cancer Using Antibody Binding to Mmp-14
Compositions and Methods for Treating Osteolytic Disorders Comprising Mmp-14 Binding Proteins
Evaluating Mmp Expression in Patient Stratification and Other Therapeutic, Diagnostic and Prognostic Methods for Cancer
Application:
13/454,534 →
Publication:
US 2013/0244890
Combination Therapy Comprising an Mmp-14 Binding Protein
Application:
61/549,873 →
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Nov 16, 2012
From: CONCORDIA PHARMACEUTICALS, INC.
To: CONCORDIA PHARMACEUTICALS, LLC
Reel/Frame 029370/0452 →
Assignment of Assignor's Interest
Nov 19, 2012
From: CONCORDIA PHARMACEUTICALS, LLC
To: KADMON CORPORATION, LLC
Reel/Frame 029384/0407 →
Security Agreement
Feb 7, 2013
From: KADMON CORPORATION, LLC
To: CORTLAND CAPITAL MARKET SERVICES LLC
Reel/Frame 029777/0502 →
Security Agreement
Jun 25, 2013
From: KADMON CORPORATION LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030679/0212 →
Security Agreement
Jun 25, 2013
From: KADMON CORPORATION LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030679/0116 →
Assignment of Assignor's Interest
May 1, 2015
From: DEVY, LAETITIA; PIETERS, HENK; LADNER, ROBERT C.; HOET, RENE
To: DYAX CORP.
Reel/Frame 035543/0347 →
Security Interest
Aug 31, 2015
From: KADMON CORPORATION, LLC
To: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
Reel/Frame 036515/0084 →
Release of Security Interest
Sep 1, 2015
From: MACQUARIE US TRADING LLC
To: KADMON CORPORATION, LLC
Reel/Frame 036518/0862 →
Security Interest
Sep 8, 2015
From: KADMON CORPORATION, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 036573/0001 →
Nunc Pro Tunc Assignment
Jul 15, 2016
From: CONCORDIA PHARMACEUTICALS, INC.
To: KADMON CORPORATION, LLC
Reel/Frame 039166/0591 →
Assignment of Assignor's Interest
Jul 22, 2016
From: KADMON CORPORATION, LLC
To: RAMOT AT TEL-AVIV UNIVERSITY LTD.
Reel/Frame 039225/0943 →
Corrective Assignment to Correct the Assignor's Name Previously Recorded at Reel: 039166 Frame: 0591. Assignor(S) Hereby Confirms the Assignment.
Aug 16, 2016
From: CONCORDIA PHARMACEUTICALS, LLC
To: KADMON CORPORATION, LLC
Reel/Frame 040314/0329 →
Assignment of Assignor's Interest
Jul 2, 2018
From: DEVY, LAETITIA; PIETERS, HENK; LADNER, ROBERT C.; HOET, RENE
To: DYAX CORP.
Reel/Frame 046254/0393 →
Termination of Patent and Trademark Security Agreement
Nov 25, 2019
From: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
To: KADMON CORPORATION, LLC
Reel/Frame 051106/0677 →
Assignment of Assignor's Interest
May 18, 2021
From: DYAX CORP.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056268/0983 →
Merger and Change of Name
Sep 10, 2021
From: SURFACE LOGIX, INC.; SURFACE LOGIX, LLC
To: SURFACE LOGIX, LLC
Reel/Frame 057468/0052 →
Release of Security Interest
Oct 29, 2021
From: MACQUARIE US TRADING LLC
To: KADMON CORPORATION, LLC
Reel/Frame 057973/0751 →
Entity Conversion
Sep 17, 2025
From: SURFACE LOGIX, INC.
To: SURFACE LOGIX LLC
Reel/Frame 072915/0828 →